Literature DB >> 29389502

The prevalence of sick leave: Reasons and associated predictors - A survey among employed pregnant women.

Mette Backhausen1, Peter Damm2, Jane Bendix3, Ann Tabor2, Hanne Hegaard4.   

Abstract

OBJECTIVE: We aimed to investigate the prevalence of sick leave and self-reported reasons given for sick leave during pregnancy. Furthermore, we aimed to estimate the frequency of long-term sick leave during pregnancy in relation to pre-baseline maternal characteristics and to identify predictors of long-term sick leave.
METHOD: Data from 508 employed pregnant women seeking antenatal care was collected by questionnaires from August 2015 to March 2016. The questionnaires, which were filled in at 20 and 32 weeks of gestation, provided information on maternal characteristics, the number of days spent on sick leave and the associated reasons. Descriptive statistics and logistic regression analysis were applied.
RESULTS: The prevalence of sick leave was 56% of employed pregnant women in the first 32 weeks of gestation and more than one in four reported long-term sick leave (>20 days, continuous or intermittent). Low back pain was the reason most frequently stated. Fewer than one in ten stated that their sick leave was due to work-related conditions. Positive predictors of long-term sick leave were multiparity, pre-pregnancy low back pain and mental disease, while an advanced degree education was a negative predictor.
CONCLUSIONS: The prevalence of sick leave was 56% in the first 32 weeks of gestation and more than one in four women reported long-term sick leave. The majority of reasons for sick leave were pregnancy-related and low back pain was the most frequently given reason.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29389502     DOI: 10.1016/j.srhc.2017.11.005

Source DB:  PubMed          Journal:  Sex Reprod Healthc        ISSN: 1877-5756


  7 in total

1.  Reflections on workplace adjustments for pregnant employees: a qualitative study of the experiences of pregnant employees and their managers.

Authors:  Dorte Raaby Andersen; Anne-Mette Hedeager Momsen; Pernille Pedersen; Rikke Damkjær Maimburg
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-01       Impact factor: 3.105

2.  Compression shorts reduce prenatal pelvic and low back pain: a prospective quasi-experimental controlled study.

Authors:  Jaclyn M Szkwara; Wayne Hing; Rodney Pope; Evelyne Rathbone
Journal:  PeerJ       Date:  2019-06-20       Impact factor: 2.984

3.  Experiences managing pregnant hospital staff members using an active management policy-A qualitative study.

Authors:  Mette G Backhausen; Mette Langeland Iversen; Margrethe Bordado Sköld; Thora G Thomsen; Luise Moellenberg Begtrup
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

4.  Validation of self-administered tests for screening for chronic pregnancy-related pelvic girdle pain.

Authors:  Monika Fagevik Olsén; Paulina Körnung; Sophie Kallin; Helen Elden; Gunilla Kjellby Wendt; Annelie Gutke
Journal:  BMC Musculoskelet Disord       Date:  2021-03-01       Impact factor: 2.362

5.  Body perception disturbances in women with pregnancy-related lumbopelvic pain and their role in the persistence of pain postpartum.

Authors:  Nina Goossens; Inge Geraerts; Lizelotte Vandenplas; Zahra Van Veldhoven; Anne Asnong; Lotte Janssens
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-18       Impact factor: 3.007

6.  Physical therapists' experiences and perceptions of antepartum and postpartum care.

Authors:  Kuan-Yin Lin; Yi-Ju Tsai; Jeng-Feng Yang; Meng-Hsing Wu
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-03       Impact factor: 3.007

7.  Occupational stress is associated with job performance among pregnant women in Japan: comparison with similar age group of women.

Authors:  Yasuka Nakamura; Yoko Sumikawa Tsuno; Aya Wada; Keiko Nagasaka; Maiko Kawajiri; Yoko Takeishi; Mikako Yoshida; Toyoko Yoshizawa
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-05       Impact factor: 3.105

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.